| 1 |
15654538 | [Monoclonal antibody therapy for malignant lymphoma]. | 2005 Jan 15 |
3 |
| 2 |
14748653 | Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphoma. | 2004 Feb |
1 |
| 3 |
15517123 | [Monoclonal antibody treatment of malignant lymphoma]. | 2004 Dec |
1 |
| 4 |
15640794 | Tositumomab and iodine [131I] tositumomab in the management of follicular lymphoma. An oncologist's view. | 2004 Dec |
1 |
| 5 |
12899647 | Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab. | 2003 |
2 |
| 6 |
12939722 | Radioimmunotherapy for non-Hodgkin's lymphoma. | 2003 Aug |
1 |
| 7 |
11877757 | Choosing an optimal radioimmunotherapy dose for clinical response. | 2002 Feb 15 |
1 |
| 8 |
11877767 | High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study. | 2002 Feb 15 |
2 |
| 9 |
11960274 | Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine (131)I tositumomab). | 2002 Mar |
1 |
| 10 |
11049969 | A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. | 2000 Nov 1 |
1 |
| 11 |
11125287 | [Immunotargeting of tumors: state of the art and prospects in 2000]. | 2000 Nov |
1 |
| 12 |
11701541 | Managing Indolent Lymphomas in Relapse: Working Our Way Through a Plethora of Options. | 2000 |
1 |
| 13 |
10561019 | Radiolabeled antibody therapy of B-cell lymphomas. | 1999 Oct |
1 |
| 14 |
9779701 | Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. | 1998 Oct |
1 |